An earlier study has demonstrated that the leukemia-microenvironment association protects CML stem/progenitor cells from tyrosine kinase inhibitor treatment through N-cadherin signaling23. This evidence concerns the gene CDH2 and chronic myelogenous leukemia, BCR-ABL1 positive.